Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study

CompletedOBSERVATIONAL
Enrollment

2,600

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2019

Conditions
Liver Failure, Acute on Chronic
Interventions
OTHER

Standary therapy

Standary therapy for chronic liver disease with ALI and/or AD

Trial Locations (16)

100015

Ditan Hospital of integrated traditional Chinese and Western Medicine Center, Beijing

130021

The First Affiliated Hospital of Jilin University, Changchun

200001

Fudan University Huashan hospital, Shanghai

Fudan University Zhongshan hospital, Shanghai

Renji hospital of Shanghai Jiao Tong University School of Medical, Shanghai

200083

Shanghai Public Health Clinical Center, Shanghai

250033

Affiliated Hospital of the Armed Police Logistics College, Tianjingcun

The Second Hospital of Shandong University, Jinan

350025

Fuzhou general hospital of Xiamen university, Fuzhou

400038

Southwest Hospital of Third Military Medical University, Chongqing

410008

Xiangya hospital of Central South University, Changsha

430022

Wuhan Union Hospital of Huazhong University of Science and Technology, Wuhan

442000

Taihe Hospital, Shiyan

450003

Henan Provincial People's Hospital, Zhengzhou

510515

Southern hospital infection department, Guangzhou

830054

The First Teaching Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
lead

Hai Li

OTHER

NCT02457637 - Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study | Biotech Hunter | Biotech Hunter